Tag: FDA stability

Addressing Gaps in Stability Data Prior to Submission Filing Pharmaceutical companies often encounter stability data gaps during product development, which can pose significant challenges just before submission filing. These gaps…

Addressing Regulatory Issues in Stability Protocol Deviations and Missed Pulls In the realm of pharmaceutical manufacturing, adherence to stability protocols is paramount for ensuring product quality and compliance with regulatory…

Effective Preparation of Stability Summaries for Annual Product Quality Review Stability summaries are critical components of the Annual Product Quality Review (APQR) for pharmaceuticals, ensuring products meet regulatory expectations throughout…

Understanding Regulatory Guidelines for Ongoing Stability Programs in Pharmaceutical Manufacturing Many pharmaceutical manufacturers face challenges in meeting the rigorous regulatory expectations for stability studies as part of their ongoing quality…

Implementing Compliance for Stability Commitments Post-Product Approval In the dynamic environment of pharmaceutical manufacturing, adherence to regulatory expectations for stability studies is critical not only during development but also post-approval.…

Understanding Stability Study Requirements for New Strengths and Pack Sizes Pharmaceutical manufacturers often face challenges when introducing new strengths or additional pack sizes for established products. These changes necessitate thorough…